Is Gilteritinib reimbursed by medical insurance?

The original drug Gilteritinib has been approved by the National Medical Products Administration for marketing in China. It is sold under the generic name Gilteritinib Fumarate Tablets and as Segatan. However, due to its short time on the market, it is not included in the national medical insurance. Therefore, patients cannot use medical insurance for reimbursement and can only purchase it at their own expense. Giritinib is mainly used to treat a leukemia subtype calledFLT3 mutation-positive acute myeloid leukemia (FLT3, AML). It belongs to a class of drugs called tyrosine kinase inhibitors. Domestic market specifications The price of 40mg*21 tablets*2 plates per box is more than 20,000 yuan, which is relatively expensive.